Investegate |Unicyte AG Announcements | Unicyte AG: Unicyte AG, a Leader in Stem Cell Therapy Innovation, Advances Lead Program to Phase 2 Clinical Development
Investegate announcements from Unicyte AG, Unicyte AG, a Leader in Stem Cell Therapy Innovation, Advances Lead Program to Phase 2 Clinical Development
Florian Jehle Matt Steinberg Johannes Haeberle University Children Hospital Zurich Advances Lead Program To Phase Clinical Development
Source: investegate.co.uk